Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Erstklassige Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 208% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/71305/Aktiencheck_Vidac_120723.001.png
Erstklassige Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 208% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Erstkl. Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. 208% Biotech Hot Stock nach 31.205% mit Amgen

 

12.07.23 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

Carvana Is Rallying Fast, But It's Still a High-Risk Investment: https://www.marketbeat.com/logos/articles/med_20230711091301_carvana-is-rallying-fast-but-its-still-a-high-risk.jpg
Carvana Is Rallying Fast, But It's Still a High-Risk Investment

When investing in the stock market, or even just evaluating large purchases such as a car or home, it’s important not to remain anchored on data points that no longer apply.

For example, it

PriceSmart Pulls Back: A Smart Time To Buy Emerging Markets?: https://www.marketbeat.com/logos/articles/med_20230711083946_chart-psmt-7112023.png
PriceSmart Pulls Back: A Smart Time To Buy Emerging Markets?

With emerging markets expected to diverge from developed markets in the 2nd half, PriceSmart (NASDAQ: PSMT) looks like an intelligent play. According to GlobalXETFs, low valuations and secular

Grid Dynamics Welcomes Valery Zelixon, a Proven Revenue Catalyst, as Senior Vice President of Sales: https://www.irw-press.at/prcom/images/messages/2023/71295/GridDynamics_110723_ENPRcom.001.png
Grid Dynamics Welcomes Valery Zelixon, a Proven Revenue Catalyst, as Senior Vice President of Sales

Key Takeaways:

 

-          Valery Zelixon joins Grid Dynamics as Senior Vice President of Sales, and under his leadership, Grid Dynamics will enhance its focus on sales and new growth

Grid Dynamics begrüßt Valery Zelixon, eine bewährte Führungskraft für die Umsatzentwicklung, als Senior Vice President of Sales: https://www.irw-press.at/prcom/images/messages/2023/71295/GridDynamics_110723_DEPRcom.001.png
Grid Dynamics begrüßt Valery Zelixon, eine bewährte Führungskraft für die Umsatzentwicklung, als Senior Vice President of Sales

Wichtigste Eckdaten:

 

-          Valery Zelixon wechselt als Senior Vice President of Sales zu Grid Dynamics. Unter seiner Führung wird Grid Dynamics seinen Fokus auf Vertrieb und neue

Could CAVA Be The Next Chipotle? Here's How Close It Gets: https://www.marketbeat.com/logos/articles/med_20230711072351_could-cava-be-the-next-chipotle-heres-how-close-it.jpg
Could CAVA Be The Next Chipotle? Here's How Close It Gets

The United States IPO (Initial Public Offering) market had been on a dry spell during the past few months due to more challenging than average financing rates and hurdles, aided by a FED acting to

This Autonomous Vehicle Stock Doubled in June and May Do It Again: https://www.marketbeat.com/logos/articles/med_20230711071116_this-autonomous-vehicle-stock-doubled-in-june-and.jpg
This Autonomous Vehicle Stock Doubled in June and May Do It Again

Like the classic Willie Nelson song, self-driving technology company Aurora Innovation, Inc. (NASDAQ: AUR) is “on the road again.” 

The former SPAC winner turned penny stock loser is up 131% this

Massive Upside Forecasted In Alta Equipment Group: https://www.marketbeat.com/logos/articles/med_20230711070604_massive-upside-forecasted-in-alta-equipment-group.jpg
Massive Upside Forecasted In Alta Equipment Group

Only sometimes do investors get the opportunity to consider cyclically favorable sectors and, even harder still, to successfully pick a stock within the sector that is set to outperform its peers

Is Samsung's Warning Of A Chip Glut Hurting DRAM Maker Micron?: https://www.marketbeat.com/logos/articles/med_20230710123921_is-samsungs-warning-of-a-chip-glut-hurting-dram-ma.jpg
Is Samsung's Warning Of A Chip Glut Hurting DRAM Maker Micron?

Remember the pandemic-era chip shortage? Well, that’s history now, and there’s currently a chip glut, according to Samsung Electronics Co., Ltd. (OTCMKTS: SSNLF), which warned that its profit

Genius Sports Scores an 18-Month High on NFL Deal: https://www.marketbeat.com/logos/articles/med_20230711134936_genius-sports-scores-an-18-month-high-on-nfl-deal.jpg
Genius Sports Scores an 18-Month High on NFL Deal

Sports technology player Genius Sports Limited (NYSE: GENI) is mounting quite the comeback. A year removed from a crushing 10-month losing streak, shares of the London-based company have surged

Accolade: A Rising Personalized AI-Powered Healthcare Platform: https://www.marketbeat.com/logos/articles/med_20230709131618_chart-accd.jpg
Accolade: A Rising Personalized AI-Powered Healthcare Platform

Accolade Inc. (NASDAQ: ACCD) is an artificial intelligence (AI) powered healthcare platform that provides personalized healthcare guidance for employers and workers. The platform helps people

3 Oil Stocks to Buy Before the Price of Crude Takes Off: https://www.marketbeat.com/logos/articles/med_20230710124152_3-oil-stocks-to-buy-before-the-price-of-crude-take.jpg
3 Oil Stocks to Buy Before the Price of Crude Takes Off

As is often the case with equity markets, stocks that perform well one year lag the market the following year. That’s been the case with energy stocks, and in particular oil stocks, which are

3 Stocks that Analysts Continue to Upgrade into Earnings Season: https://www.marketbeat.com/logos/articles/med_20230710103919_3-stocks-that-analysts-continue-to-upgrade-into-ea.jpg
3 Stocks that Analysts Continue to Upgrade into Earnings Season

One simple signal that investors can use to decide if a stock is likely to move higher is to look at analyst sentiment. An analyst is a market professional employed by either funds that buy

Meta Threads Its Way To New Heights: https://www.marketbeat.com/logos/articles/med_20230710095453_chart-meta-7102023.png
Meta Threads Its Way To New Heights

Meta (NASDAQ: META) took the tech world by storm again with its Threads announcement. Threads is a new app built by the Instagram team that allows functionality akin to Twitter. Users log in using

Profit Taking Hits Home for Specialty Retailers: https://www.marketbeat.com/logos/articles/med_20230710083233_profit-taking-hits-home-for-specialty-retailers.jpg
Profit Taking Hits Home for Specialty Retailers

Americans returned from the 4th of July holiday to find the U.S. equity markets in a less than celebratory mood. 

Stronger than expected economic data, including Thursday’s sharp jump in private

The 3 Hot Sectors To Watch During The Summer Reporting Season: https://www.marketbeat.com/logos/articles/med_20230710080927_chart-xlc-7102023.png
The 3 Hot Sectors To Watch During The Summer Reporting Season

Market participants may have positioned in May and gone away, but the analysts have remained active. They continue to update the earnings outlook, and the first few reports from S&P 500 (NYSEARCA:

Time to Ring the Register on DoorDash Stock?: https://www.marketbeat.com/logos/articles/med_20230709131955_chart-dash.jpg
Time to Ring the Register on DoorDash Stock?

Food delivery platform DoorDash Inc. (NASDAQ: DASH) shares have climbed 61% in 2023. While it's still trading well below its all-time high of $257.25, achieved in November 2021, investors may use

Can ChatGPT AI Revitalize Microsoft's Bing Search Engine?: https://www.marketbeat.com/logos/articles/med_20230709132206_chart-msft.jpg
Can ChatGPT AI Revitalize Microsoft's Bing Search Engine?

Technology provider Microsoft Co. (NYSE: MSFT) has garnered much of the spotlight in mainstream artificial intelligence (AI) adoption in 2023. Open.ai’s launch of ChatGPT kicked off the AI mania

Biogen Shares Fall After FDA Approval Of Alzheimer's Drug Leqembi: https://www.marketbeat.com/logos/articles/med_20230707134150_biogen-shares-fall-after-fda-approval-of-alzheimer.jpg
Biogen Shares Fall After FDA Approval Of Alzheimer's Drug Leqembi

Stocks often react differently from the way you think they might. That happened on July 7 as shares of Biogen Inc. (NASDAQ: BIIB) swooned 2.88% in heavy trading volume following news of full

Enphase Energy is Still Converting Solar Energy into Profits: https://www.marketbeat.com/logos/articles/med_20230709131819_chart-enph2.jpg
Enphase Energy is Still Converting Solar Energy into Profits

Solar energy products maker Enphase (NYSE: ENPH) stock has fallen from grace after hitting all-time highs near $340 in December 2022, losing more than half its value by July 2023. The company was

Why Buying The Dip In Alphabet (Google) Could Yield Big Returns: https://www.marketbeat.com/logos/articles/med_20230710053121_why-buying-the-dip-in-google-could-yield-big-retur.jpg
Why Buying The Dip In Alphabet (Google) Could Yield Big Returns

Alphabet shares (NASDAQ: GOOGL) are finding support at a previous area of resistance, pointing toward a potential upside in the stock if buyers can continue to stand firm. On the year, shares of

EV Mixed Signals: Sales Are Rising, But Inventory Slower To Move: https://www.marketbeat.com/logos/articles/med_20230710052454_ev-mixed-signals-sales-are-rising-but-inventory-sl.jpg
EV Mixed Signals: Sales Are Rising, But Inventory Slower To Move

Sales of electric vehicles are continuing to grow, but at a slower pace, according to Cox Automotive, which provides marketing and financing services to the auto industry.

The EV industry is

Pfizer Just Invested $25 million In This Biotech: https://www.marketbeat.com/logos/articles/med_20230707085820_pfizer-just-invested-25-million-in-this-biotech.jpg
Pfizer Just Invested $25 million In This Biotech

Shares of Caribou Biosciences (NASDAQ: CRBU) were up 45% yesterday after Pfizer (NYSE: PFE) made a $25 million equity investment. On Thursday, the company said Pfizer bought almost 4.7 million